Submission Details
| 510(k) Number | K251291 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 25, 2025 |
| Decision Date | July 03, 2025 |
| Days to Decision | 69 days |
| Submission Type | Traditional |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Summary PDF |
K251291 is an FDA 510(k) clearance for the Advanix? Pancreatic Stent and NaviFlex? Rapid Exchange (RX) Pancreatic Delivery System and Pushers, a Stents, Drains And Dilators For The Biliary Ducts (Class II — Special Controls, product code FGE), submitted by Boston Scientific (Malborough, US). The FDA issued a Cleared decision on July 3, 2025, 69 days after receiving the submission on April 25, 2025. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5010.
| 510(k) Number | K251291 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 25, 2025 |
| Decision Date | July 03, 2025 |
| Days to Decision | 69 days |
| Submission Type | Traditional |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Summary PDF |
| Product Code | FGE — Stents, Drains And Dilators For The Biliary Ducts |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 876.5010 |